What OMICSLAB does

OMICSLAB (ООО «ОмиксЛаб») is a Russian bioinformatics and omics-services company founded in 2017 and headquartered in Moscow, with Skolkovo Foundation resident status since the same year. The firm delivers end-to-end next-generation sequencing analytics across transcriptomics, genomics, epigenomics and proteomics, combining wet-lab-adjacent interpretation with custom software development. Its client base consists of research institutions, biotech and pharma organizations in Russia, served through project-based engagements rather than disclosed recurring contracts.

The company's product surface centers on two registered software assets: OmicsPipe, an omnibus analytics pipeline platform released and entered into the Russian Unified Software Register in 2024, and OmicsDepression, a specialized psychiatric-genomics tool registered in 2021. The underlying technical stack spans Python, R, Go, JavaScript, Django, React, PostgreSQL and Redis, with machine learning applied to mutation analysis, gene-level interpretation, pathway reconstruction and candidate drug-target identification. ML is integrated into the analytical workflow rather than marketed as a standalone product. Datasets from the GEO, TCGA and Broad Institute public repositories are incorporated into the analytical pipelines.

OMICSLAB's commercial model rests on three legs: (1) custom omics-services projects priced at approximately 6,000 RUB per hour, (2) licensing and support for the OmicsPipe platform across community, standard and commercial tiers, and (3) technology-enabled service partnerships across the major NGS hardware vendors (Illumina, BGI, MGI, Oxford Nanopore, Genomed, Sesana). In October 2024 the firm obtained IT company accreditation (registry №65044, dated 22.10.2024) and inclusion in the Unified Russian Software Register, positioning it for government and quasi-government procurement preference and tax benefits. The company has received a Skolkovo Foundation prize for educational activities, indicating formal ecosystem endorsement.

Name

OMICSLAB

Legal name

ООО «ОмиксЛаб»

Website

https://omicslab.ru

Company type

Private

Founded year

2017

Operating status

Operating

Short description

OMICSLAB is a Moscow-based Russian bioinformatics firm (founded 2017, Skolkovo resident) that delivers omics analytics — transcriptomics, genomics, epigenomics, proteomics — and the OmicsPipe and OmicsDepression software platforms to research institutions, biotech and pharma clients.

Ownership category

akta.pro rank

Product category

Bioinformatics & Omics Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)

Keywords

• Bioinformatics services
• Genomic sequencing
• Transcriptomic analysis
• Proteomic profiling
• DNA sequencing software

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Custom IT Development & Research Services: OmicsLab provides custom bioinformatics research and software development services priced at 6,000 RUB/hour. Services include experimental design (microarray, NGS, PCR), laboratory work with cell lines and lab animals, bioinformatics analysis using statistics and machine learning, and bespoke IT solution development. Pricing is quote-based with final cost determined after requirements clarification. Skolkovo residents receive discounts and full expense reimbursement under grant programs. Service is VAT-exempt as a Skolkovo resident.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

OmicsLab designs and executes custom omics research projects (experimental design, NGS and microarray laboratory work, cell line and animal model experiments) and develops bespoke bioinformatics and IT solutions for DNA sequencing data analysis. The company sells proprietary registered software products — OmicsPipe (DNA sequencing data transformation with containerized pipelines) and OmicsDepression (depression-focused omics software) — and delivers results via statistics, machine learning, and visualization (heatmaps, 2D/3D graphs) for scientific publication.

Product overview

OmicsLab is a Russian biotech company providing omics technologies for research. The portfolio consists of two registered software products: OmicsPipe (a platform for DNA sequencing data transformation and bioinformatics analysis using containerization, launched 2024) and OmicsDepression (specialized software for depression research, launched 2021). Services include experimental design, laboratory work with cell lines and laboratory animals, unique bioinformatics data analysis methods using Machine Learning, research extension with international database comparisons (GEO, TCGA, Broad Institute), result visualization, and custom IT solution development.

Differentiator

Problem solved

Functional benefit

Brands

• OmicsPipe: Software for sequential transformation of DNA sequencing data (FASTQ files) from next-generation sequencers, using declarative style description with containerization for system dependency management and result reproducibility.
• OmicsDepression

Products and services

• OmicsPipe Software for sequential transformation of DNA sequencing data (FASTQ files) from next-generation sequencers using declarative-style pipeline descriptions with containerization for system dependency management and result reproducibility. Used in scientific research and medical activity for data accumulation and analysis, including new molecular target discovery, drug efficacy research, and clinical-pathological dependency analysis. Listed in the Unified Register of Russian Software (registry entry №24358 from 18.10.2024).
• OmicsDepression Registered software program (FIPS certificate № 2021668299 from 12.11.2021) specialized for depression-related omics analysis. Designed for bioinformatics analysis focused on depression research, available through OmicsLab programs for relevant research institutions and biotech/pharma clients.
• Custom Omics Research & Bioinformatics Services

Quantifiable outcome

• Unprecedented speed for the biomedical industry through established technological processes and a broad partner network

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Partnerships

Four partnerships are on record, tiered core.

• GEO (Gene Expression Omnibus)coreTechnology or IntegrationGEO is an international database of gene expression experiments maintained by NCBI. OmicsLab compares client data against more than 1.5 million GEO samples, enabling large-scale benchmarking and harmonization of research data.
• TCGA (The Cancer Genome Atlas)coreTechnology or IntegrationTCGA is a landmark cancer genomics program. OmicsLab leverages TCGA data alongside GEO and Broad Institute to compare client samples against over 1.5 million reference samples for biomarker discovery and molecular target identification.
• Broad InstitutecoreTechnology or IntegrationBroad Institute of MIT and Harvard is a leading genomics research center. OmicsLab integrates Broad Institute data into its comparison and harmonization workflows alongside GEO and TCGA, covering over 1.5 million reference samples.
• Skolkovo FoundationcoreStrategic or Co-development PartnerThe Skolkovo Foundation manages Russia's Skolkovo innovation center. OmicsLab is an official resident company (OGRN 5177746051577), enabling access to tax benefits, grants, and the Skolkovo innovation ecosystem for R&D collaboration and client referrals.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Congenica: Clinical genomics and multi-omic data interpretation platform using ML for variant and biomarker analysis. Comparable in using ML-driven interpretation over large reference datasets to deliver diagnostic-grade insights.
• Strand Life Sciences: Bioinformatics and clinical genomics company offering multi-omic data analysis, variant interpretation, and pharma biomarker discovery services. Comparable in combining bioinformatics software with services for clinical and pharma customers.
• Partek (part of Illumina): Bioinformatics software for genomic, transcriptomic, and multi-omic analysis with ML/statistics. Competes with OmicsPipe in the analytics software layer used by research biologists and bioinformaticians.

Direct peers

• Genomed: Russian genomics and sequencing services company displayed as a partner on OmicsLab's site. Operates in the same domestic multi-omics services market and competes for the same Russian biotech, clinical, and pharma buyers.
• Velsera (formerly Seven Bridges): Bioinformatics platform offering secondary NGS analysis pipelines, data management, and multi-omics interpretation services. Comparable to OmicsLab's OmicsPipe + services combination for research and clinical genomics customers.
• Sophia Genetics: Multi-omic data analysis platform combining genomics, transcriptomics and other omics with ML-driven interpretation for clinical and research customers. Highly comparable in using AI/ML on sequencing data for biomarker and target discovery.
• DNAnexus: Cloud-based bioinformatics platform enabling genomic and multi-omic data analysis at scale. Direct overlap with OmicsLab's sequencing pipeline and analysis value proposition, especially for pharma-grade workloads.

Broad incumbents

• QIAGEN Digital Insights: Major bioinformatics and clinical genomics interpretation platform from QIAGEN. Overlaps with OmicsLab in secondary/tertiary analysis, variant interpretation, and multi-omics insights for pharma and clinical customers.
• BGI Group: World-leading genomics sequencing organization and equipment provider, listed as an OmicsLab technology partner. Competes as a much larger integrated sequencing and bioinformatics services provider with global scale.
• Genedata: Enterprise bioinformatics platform for biopharma R&D, including omics data processing and interpretation workflows. Comparable to OmicsLab in serving large pharma customers with multi-omics analysis, but at significantly larger enterprise scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OMICSLAB